Clinical Trials Directory

Trials / Unknown

UnknownNCT03666234

Idiopathic Pulmonary Fibrosis Registry China Study

Status
Unknown
Phase
Study type
Observational
Enrollment
800 (estimated)
Sponsor
Dai Huaping · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

By mean of registry of newly diagnosed Chinese IPF patients from more than 15 sites, this study aims to build IPF prospective cohort, set up normative clinical database and a biological specimen bank, and examine the clinical characteristics of newly diagnosed Chinese IPF patients, as well as the nature history, prognosis, comorbidities and complications of IPF patients in China, the current treatment pattern, burden of illness, and quality of life of Chinese IPF patients.

Conditions

Timeline

Start date
2018-07-01
Primary completion
2023-06-30
Completion
2023-06-30
First posted
2018-09-11
Last updated
2018-09-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03666234. Inclusion in this directory is not an endorsement.

Idiopathic Pulmonary Fibrosis Registry China Study (NCT03666234) · Clinical Trials Directory